AbbVie will present 46 abstracts for six investigational and approved medicines across eight cancer types A five-year update from the CLL14 Phase 3 VENCLYXTO®/VENCLEXTA® (venetoclax) and...

Since the Mitsubishi Outlander PHEV (plug-in hybrid electric vehicle) launched in 2017 as a 2018 model, the vehicle has reinforced its credentials as the best-selling PHEV sport-utility vehicle in...

Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that initial data from a Phase 1 portion of the Ph 1/2...

Arctech, the world's leading tracking, racking, and BIPV solutions provider, announced it has attended the Intersolar 2022 in Munich (Germany) from May 11th to 13th with the latest effort to...

Initial TakeAim Lymphoma combination data shows anti-cancer activity, including 1 complete response and 2 partial responses, in heavily pretreated patients including those with prior ibrutinib use...

Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies...

Air Products Foundation will Donate up to $15,000 to the AIST Foundation LEHIGH VALLEY, Pa., May 12, 2022 /PRNewswire/ -- Air Products (NYSE:APD) will showcase industrial gas solutions and...

Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people's health and the quality of patients' lives, today announced that the Company will attend the...

Abstracts represent exciting research progress across four cancers where patients have limited treatment options TOKYO, May 12, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO:

--ARU-1801 reduced vaso-occlusive events and days in the hospital for patients with severe sickle cell disease-- MILLBURN, N.J. and BASEL, Switzerland, May 12, 2022 /PRNewswire/ -- Aruvant Sciences ("